CORRESP 1 filename1.htm

A.G.P. / Alliance Global Partners

590 Madison Ave., 28th Floor

New York, NY 10022

 

December 20, 2023

 

VIA EDGAR

 

U.S. Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549

 

  Re: CNS Pharmaceuticals Inc.
    Registration Statement on Form S-1
   

Filed December 8, 2023

File No: 333-275973

     

 

Ladies and Gentlemen:

 

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended (the “Securities Act”), A.G.P / Alliance Global Partners as lead Placement Agent, hereby requests acceleration of the effective date of the above-referenced Registration Statement so that it will become effective at 5:00pm Eastern Time on December 21, 2023 or as soon thereafter as practicable.

 

 

  Very truly yours,
   
  A.G.P / Alliance Global Partners
   
     
  By: /s/ Thomas J. Higgins
  Name: Thomas J. Higgins
  Title: Managing Director